Interregulation between fragile X mental retardation protein and methyl CpG binding protein 2 in the mouse posterior cerebral cortex.
Interregulation between fragile X mental retardation protein and methyl CpG binding protein 2 in the mouse posterior cerebral cortex.
复制标题
脆性X智力低下蛋白与甲基CpG结合蛋白2在小鼠大脑后皮层的相互调节
DOI:
10.1093/hmg/ddaa226
复制
发表时间:
2021-02-04
影响因子:
3.5
通讯作者:
Hampson DR
中科院分区:
文献类型:
--
作者:
Arsenault J;Hooper AWM;Gholizadeh S;Kong T;Pacey LK;Koxhioni E;Niibori Y;Eubanks JH;Wang LY;Hampson DR
Several X-linked neurodevelopmental disorders including Rett syndrome, induced by mutations in the MECP2 gene, and fragile X syndrome (FXS), caused by mutations in the FMR1 gene, share autism-related features. The mRNA coding for methyl CpG binding protein 2 (MeCP2) has previously been identified as a substrate for the mRNA-binding protein, fragile X mental retardation protein (FMRP), which is silenced in FXS. Here, we report a homeostatic relationship between these two key regulators of gene expression in mouse models of FXS (Fmr1 Knockout (KO)) and Rett syndrome (MeCP2 KO). We found that the level of MeCP2 protein in the cerebral cortex was elevated in Fmr1 KO mice, whereas MeCP2 KO mice displayed reduced levels of FMRP, implicating interplay between the activities of MeCP2 and FMRP. Indeed, knockdown of MeCP2 with short hairpin RNAs led to a reduction of FMRP in mouse Neuro2A and in human HEK-293 cells, suggesting a reciprocal coupling in the expression level of these two regulatory proteins. Intra-cerebroventricular injection of an adeno-associated viral vector coding for FMRP led to a concomitant reduction in MeCP2 expression in vivo and partially corrected locomotor hyperactivity. Additionally, the level of MeCP2 in the posterior cortex correlated with the severity of the hyperactive phenotype in Fmr1 KO mice. These results demonstrate that MeCP2 and FMRP operate within a previously undefined homeostatic relationship. Our findings also suggest that MeCP2 overexpression in Fmr1 KO mouse posterior cerebral cortex may contribute to the fragile X locomotor hyperactivity phenotype. Interregulation between MeCP2 and FMRP. MeCP2, a transcriptional modulator, contributes to the upregulation of FMRP expression. FMRP, a translational modulator, contributes to the downregulation of MeCP2 translation. MeCP2 KO mice are hypoactive. Fmr1 KO mice display hyperactivity.
登录
查看更多内容
影响因子:
4.5
作者:
Li R;Dong Q;Yuan X;Zeng X;Gao Y;Chiao C;Li H;Zhao X;Keles S;Wang Z;Chang Q
通讯作者:
Chang Q
影响因子:
16.2
作者:
Edbauer, Dieter;Neilson, Joel R.;Foster, Kelly A.;Wang, Chi-Fong;Seeburg, Daniel P.;Batterton, Matthew N.;Tada, Tomoko;Dolan, Bridget M.;Sharp, Phillip A.;Sheng, Morgan
通讯作者:
Sheng, Morgan
影响因子:
2.9
作者:
Gholizadeh, Shervin;Halder, Sebok Kuvnar;Hampson, David R.
通讯作者:
Hampson, David R.
影响因子:
--
作者:
Gholizadeh, Shervin;Tharmalingam, Sujeenthar;Hampson, David R.
通讯作者:
Hampson, David R.
影响因子:
7.6
作者:
Gholizadeh, Shervin;Arsenault, Jason;Hampson, David R.
通讯作者:
Hampson, David R.